Clinical studies have shown that patients with CRC often exhibit a functional iron deficiency—characterized by low serum iron and % transferrin saturation despite preserved or elevated ferritin levels—but the implications of these changes in tumor biology remain largely unexplored [9,10,11]. The gene discussed is TF; the disease is colorectal carcinoma.